Uncovering the persistent gap: The ongoing challenge of integrating sex and gender in biomedical research

Fundings

This work was funded by the European Union's Horizon 2020 Research and Innovation Programme under grant No. 896932 (TTV guide TX project) and grant No. 824087 (EOSC-Life).

Acknowledgments

None.

References

[1] Cirrincione LR, Grieve VLB, Holloway J, et al. Inclusion of transgender and gender diverse people in phase Ⅲ trials: examples from HIV pharmacologic prevention studies[J]. Clin Pharmacol Ther, 2023, 113(3): 557-564. doi: 10.1002/cpt.2801

[2] Liu KA, Dipietro Mager NA. Women's involvement in clinical trials: historical perspective and future implications[J]. Pharm Pract (Granada), 2016, 14(1): 708. doi: 10.18549/PharmPract.2016.01.708

[3] Cameron A, Tedds LM. Gender-based analysis plus (GBA+) and intersectionality: overview, an enhanced framework, and a British Columbia case study[EB/OL]. [2024-08-25]. https://bcbasicincomepanel.ca/wp-content/uploads/2021/01/Gender_Based_Analysis_Plus_GBA_and_Intersectionality_Overview_an_Enhanced_Framework_and_a_British_Columbia_Case_Study.pdf.

[4] Rotz S, Rose J, Masuda J, et al. Toward intersectional and culturally relevant sex and gender analysis in health research[J]. Soc Sci Med, 2022, 292: 114459. doi: 10.1016/j.socscimed.2021.114459

[5] White J, Tannenbaum C, Klinge I, et al. The integration of sex and gender considerations into biomedical research: lessons from international funding agencies[J]. J Clin Endocrinol Metab, 2021, 106(10): 3034-3048. doi: 10.1210/clinem/dgab434

[6] Day S, Mason R, Lagosky S, et al. Integrating and evaluating sex and gender in health research[J]. Health Res Policy Syst, 2016, 14(1): 75. doi: 10.1186/s12961-016-0147-7

[7] Ritz SA, Antle DM, Côté J, et al. First steps for integrating sex and gender considerations into basic experimental biomedical research[J]. FASEB J, 2013, 28(1): 4-13. https://europepmc.org/article/MED/24056086

[8] Tannenbaum C, Ellis RP, Eyssel F, et al. Sex and gender analysis improves science and engineering[J]. Nature, 2019, 575(7781): 137-146. doi: 10.1038/s41586-019-1657-6

[9] Tannenbaum C, Day D. Age and sex in drug development and testing for adults[J]. Pharmacol Res, 2017, 121: 83-93.

[10] Schiebinger L, Klinge I, Sánchez de Madariaga I, et al. Gendered innovations in science, health & medicine, engineering, and environment[EB/OL]. [2024-08-25]. https://genderedinnovations.stanford.edu/.

[11] Canadian Institute of Health Research. How to integrate sex and gender into research[EB/OL]. [2024-08-25]. https://cihr-irsc.gc.ca/e/50836.html.

[12] NIH. Policy on sex as a biological variable[EB/OL]. [2024-08-25]. https://orwh.od.nih.gov/sex-gender/orwh-mission-area-sex-gender-in-research/nih-policy-on-sex-as-biological-variable.

[13] CIOMS+GENDRO. Sex and gender considerations in research: the role of research ethics guidelines and research ethics committees[EB/OL]. [2024-08-25]. https://e32fc2bb-855d-4cd5-b886-f15846b5cab3.filesusr.com/ugd/73a990_4c20d0f3b8a14891b01aa1d12dacad23.pdf.

[14] European Institute of Women's Health. Sex and gender in medicines regulation[EB/OL]. [2024-08-25]. https://eurohealth.ie/wp-content/uploads/2018/05/Sex-and-Gender-in-Medicines.pdf.

[15] Stamatiou R, Kararigas G. Participation of transgender and gender diverse persons in cardiovascular clinical trials[J]. Am Heart J Plus, 2024, 44: 100420. https://www.sciencedirect.com/science/article/pii/S2666602224000636

[16] DuBois LZ, Gibb JK, Juster RP, et al. Biocultural approaches to transgender and gender diverse experience and health: integrating biomarkers and advancing gender/sex research[J]. Am J Hum Biol, 2021, 33(1): e23555. doi: 10.1002/ajhb.23555

[17] Johnson JL, Greaves L, Repta R. Better science with sex and gender: facilitating the use of a sex and gender-based analysis in health research[J]. Int J Equity Health, 2009, 8: 14. doi: 10.1186/1475-9276-8-14

[18] Kacel EL, Pankey TL, Vencill JA, et al. Include, affirm, and empower: a paradigm shift in cancer clinical trials for sexual and gender diverse populations[J]. Ann LGBTQ Public Popul Health, 2022, 3(1): 18-40. doi: 10.1891/LGBTQ-2021-0013

[19] Peckham H, Webb K, Rosser EC, et al. Gender-diverse inclusion in immunological research: benefits to science and health[J]. Front Med, 2022, 9: 909789. doi: 10.3389/fmed.2022.909789

[20] Witt A, Politis M, Norton R, et al. Integrating sex and gender into biomedical research requires policy and culture change[J]. NPJ Womens Health, 2024, 2(1): 23. doi: 10.1038/s44294-024-00027-x

[21] Heidari S, Babor TF, De Castro P, et al. Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use[J]. Res Integr Peer Rev, 2016, 1: 2. doi: 10.1186/s41073-016-0007-6

[22] CIOMS. International ethical guidelines for health-related research involving humans[R]. Geneva, Switzerland: CIOMS, 2016.

[23] Saxena A, Lasher E, Somerville C, et al. Considerations of sex and gender dimensions by research ethics committees: a scoping review[J]. Int Health, 2022, 14(6): 554-561. doi: 10.1093/inthealth/ihab093

[24] Schiebinger L, Klinge I, Sánchez de Madariaga I, et al. Gendered innovation in science, health & medicine, engineering, and environment. Case studies[EB/OL]. [2024-08-25]. https://genderedinnovations.stanford.edu/fix-the-knowledge.html.

[25] Schiebinger L, Schraudner M. Interdisciplinary approaches to achieving gendered innovations in science, medicine, and engineering[J]. Interdiscip Sci Rev, 2011, 36(2): 154-167. doi: 10.1179/030801811X13013181961518